Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands |
Mar. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||
| Tax and related expenses | $ 15,165 | $ 15,165 |
| Other | 3,407 | 3,897 |
| Total accrued expenses and other current liabilities | 37,746 | 38,473 |
| Supply Agreement | Vaxcyte | ||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||
| Collaboration and license agreements and supply agreement accruals | 7,375 | 6,933 |
| CMO | ||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||
| Collaboration and license agreements and supply agreement accruals | 6,934 | 8,195 |
| Clinical Trials | ||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||
| Collaboration and license agreements and supply agreement accruals | $ 4,865 | $ 4,283 |